CoChat

Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using an In Vivo Murine Invasive Candidiasis Model

Open access
Lepak, Alexander J., Marchillo, Karen, Andes, David R. · 2015 · Antimicrobial Agents and Chemotherapy
Cited by 95

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Echinocandins inhibit the synthesis of β-1,3- d -glucan in Candida and are the first-line therapy in numerous clinical settings. Their use is limited by poor oral bioavailability, and they are available only as intravenous therapies. Derivatives of enfumafungin are novel orally bioavailable glucan synthase inhibitors. We performed an in vivo pharmacodynamic (PD) evaluation with a novel enfumafungin derivative, SCY-078 (formerly MK-3118), in a well-established neutropenic murine model of invasive candidiasis against C. albicans , C. glabrata , and C. parapsilosis . The SCY-078 MICs varied 8-fold. Oral doses of 3.125 to 200 mg/kg SCY-078 salt in sterile water produced peak levels of 0.04 to 2.66 μg/ml, elimination half-lives of 5.8 to 8.5 h, areas under the concentration-time curve from 0 to 24 h (AUC 0–24 h ) of 0.61 to 41.10 μg · h/ml, and AUC from 0 to infinity (AUC 0—∞ ) values of 0.68 to 40.31 μg · h/ml. The pharmacokinetics (PK) were approximately linear over the dose range studied. Maximum response ( E max ) and PK/PD target identification studies were performed with 4 C. albicans , 4 C. glabrata , and 3 C. parapsilosis isolates. The PD index AUC/MIC was explored by using total ( t AUC) and free ( f AUC) drug concentrations. The maximum responses were 4.0, 4.0, and 4.3 log 10 CFU/kidney reductions for C. albicans , C. glabrata , and C. parapsilosis , respectively. The AUC/MIC was a robust predictor of efficacy ( R 2 , 0.53 to 0.91). The 24-h PD targets were a static dose of 63.5 mg/kg, a t AUC/MIC of 500, and an f AUC/MIC of 1.0 for C. albicans ; a static dose of 58.4 mg/kg, a t AUC/MIC of 315, and an f AUC/MIC of 0.63 for C. glabrata ; and a static dose of 84.4 mg/kg, a t AUC/MIC of 198, and an f AUC/MIC of 0.40 for C. parapsilosis . The mean f AUC/MIC values associated with a 1-log kill endpoint against these species were 1.42, 1.26, and 0.91 for C. albicans , C. glabrata , and C. parapsilosis , respectively. The static and 1-log kill endpoints were measured relative to the burden at the start of therapy. The static and 1-log kill doses, as well as the total and free drug AUC/MIC PD targets, were not statistically different between species but were numerically lower than those observed for echinocandins. SCY-078 is a promising novel oral glucan synthase inhibitor against Candida species, and further investigation is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.04445-14

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 95

Metadata

Authors
Lepak, A. J., Marchillo, K., & Andes, D. R.
Venue
Antimicrobial Agents and Chemotherapy
Published
2015-02
Volume
59
Issue
2
Pages
1265-1272
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2143849345
Cited by
95
References
14
FWCI
5.84
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.